Effect of Colesevelam on Liver Fat Quantified by Magnetic Resonance in Nonalcoholic Steatohepatitis: A Randomized Controlled Trial

Bile acid sequestrants (BAS) lower plasma low density lipoprotein levels and improve glycemic control. Colestimide, a BAS, has been claimed by computed tomography to reduce liver fat. Therefore, we examined the efficacy of colesevelam, a potent BAS, to decrease liver fat in patients with biopsy-prov...

Descripción completa

Detalles Bibliográficos
Autores principales: Le, Thuy-Anh, Chen, Joshua, Changchien, Christopher, Peterson, Michael R, Kono, Yuko, Patton, Heather, Cohen, Benjamin L, Brenner, David, Sirlin, Claude, Loomba, Rohit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Subscription Services, Inc., A Wiley Company 2012
Materias:
Steatohepatitis/Metabolic Liver Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3400720/
https://www.ncbi.nlm.nih.gov/pubmed/22431131
http://dx.doi.org/10.1002/hep.25731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3400720/
https://www.ncbi.nlm.nih.gov/pubmed/22431131
http://dx.doi.org/10.1002/hep.25731

Ejemplares similares